Hazel Jones

Amministratore Delegato presso Enhanc3D Genomics Ltd.

Consumer Services

Health Technology

Posizioni attive di Hazel Jones

Società	Posizione	Inizio	Fine
Enhanc3D Genomics Ltd. Enhanc3D Genomics Ltd. BiotechnologyHealth Technology Enhanc3D Genomics is a private functional genomics company based in Cambridge, UK. Enhanc3D Genomics is developing a technology to unlock the full potential of the three-dimensional organization of the human genome. The British company's focus is on the non-coding regions of the genome, aiming to identify disease-associated genetic interactions and revolutionize target and biomarker discovery. The company's unique approach has the potential to make precision medicine an everyday reality for patients. Enhanc3D Genomics Ltd. was founded by Mikhail Spivakov, Peter Fraser, and Stefan Schönfelder. The CEO is Hazel Jones.	Amministratore Delegato	-	-
	Direttore operativo	01/11/2023	14/05/2024

University of Leeds

Doctorate Degree

Distribuzione geografica

Regno Unito

Posizioni

Settori

Consumer Services	2
Health Technology	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	1
Enhanc3D Genomics Ltd. Enhanc3D Genomics Ltd. BiotechnologyHealth Technology Enhanc3D Genomics is a private functional genomics company based in Cambridge, UK. Enhanc3D Genomics is developing a technology to unlock the full potential of the three-dimensional organization of the human genome. The British company's focus is on the non-coding regions of the genome, aiming to identify disease-associated genetic interactions and revolutionize target and biomarker discovery. The company's unique approach has the potential to make precision medicine an everyday reality for patients. Enhanc3D Genomics Ltd. was founded by Mikhail Spivakov, Peter Fraser, and Stefan Schönfelder. The CEO is Hazel Jones.	Health Technology

Aziende private

Health Technology